Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
about
Post-translational regulation of endothelial nitric oxide synthase in vascular endotheliumOrganic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative StressMitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular DysfunctionMechanisms regulating endothelial permeabilityMetabolic actions of angiotensin II and insulin: a microvascular endothelial balancing actMitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stressLosartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.Endothelial nitric oxide synthase in the microcirculation.Regulation of cellular communication by signaling microdomains in the blood vessel wall.Assessment of endothelial dysfunction in childhood obesity and clinical use.Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction.NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease.The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicityProtecting against vascular disease in brainCombined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.A Proteomic Approach Identifies Candidate Early Biomarkers to Predict Severe Dengue in Children.Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targetsNucleotide excision DNA repair is associated with age-related vascular dysfunctionVitamin D and Parathyroid Hormone Relationships with Urinary Nitric Oxide Metabolites and Plasma Isoprostanes in African-Americans.Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability.Pim1 kinase promotes angiogenesis through phosphorylation of endothelial nitric oxide synthase at Ser-633.The atherosusceptible endothelium: endothelial phenotypes in complex haemodynamic shear stress regions in vivo.Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axisGene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells.Alpha-Asarone Protects Endothelial Cells from Injury by Angiotensin II.Interplay of myosin phosphatase and protein phosphatase-2A in the regulation of endothelial nitric-oxide synthase phosphorylation and nitric oxide production.The Nox family of NADPH oxidases: friend or foe of the vascular system?Molecular biology of atherosclerosis.Regulation of eNOS enzyme activity by posttranslational modification.CVD and Oxidative Stress.The eNOS signalosome and its link to endothelial dysfunction.Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease.Nox, Reactive Oxygen Species and Regulation of Vascular Cell Fate.Nitric oxide donor [Ru(terpy)(bdq)NO]3+ induces uncoupling and phosphorylation of endothelial nitric oxide synthase promoting oxidant production.Mitochondrial redox plays a critical role in the paradoxical effects of NAPDH oxidase-derived ROS on coronary endothelium.Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischaemic insult: role of PYK2.Global identification of the genes and pathways differentially expressed in hypothalamus in early and established neurogenic hypertension.Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.
P2860
Q21129237-B06C55A8-56F4-4A60-91B5-CB1AB3E2AFDFQ26799354-120652A5-AEA8-40BB-840E-D938ECB1473BQ26799985-1E44CC94-8DC5-46F5-B255-6E3D4548DDFFQ26866511-EE8FA1F6-2014-4904-A062-E9CBBE7665C7Q28390079-2EEE12C0-FA25-4CE4-996F-F58383387B0FQ28660732-FFE26AD9-1762-4B23-8B56-1E8AC80E4D3FQ29347083-B8CC1B5C-0BFE-4DE2-936C-4A5E7CAA86B9Q30278654-30ACFD7B-C66B-475D-AB37-2E7309D6969EQ30406156-8D36ABEE-C8AF-4817-B9B1-AEB714453D40Q30430798-F085ED04-33F1-4F07-BCE0-C853AB459190Q30450801-5A73943B-D3E5-4E88-BA54-11B45639FD5BQ33764561-CF48AEAE-28BD-4516-9351-F31FE5423800Q34524690-92FFF684-A7B8-4E12-986D-3F9361332CADQ34979773-092D075D-C957-4E57-878F-13E9C4CD79A8Q35223489-72516B75-C964-4C40-9FBA-8AD364582974Q35928781-DED848E6-8E39-45DD-8F58-926091C64549Q35948515-EC5EBEF1-9ABD-484D-8251-753A6A2231DBQ35992729-48B198EE-A5BF-4F4C-988F-A386A8E4D1A9Q36198670-7C32A5B2-8881-4AE6-A64D-ED118DCE3543Q36206119-18E367DB-85D3-458E-A082-8F73A37E760EQ36210461-9621F8A3-F7E8-40E5-B922-4B207126BF2FQ36407484-B581CDC0-EF70-446B-8D06-315CBFB9E3A1Q36964212-6EA673EF-B349-4565-9A92-56BE8FC80350Q37101896-901F9FEE-DE8C-4C57-A6F4-8339C9E57683Q37117491-9DD7E44F-4B9C-4F25-BA99-FB25AF173C6AQ37686849-E188C44B-DB8A-447D-819E-12EE9EB7CE66Q37704798-7BBE9D65-2FC1-4F81-A829-983CDBCA5D25Q37954511-5C3A074A-D0B9-43B6-B87F-B7BEEEB2BC6BQ38125279-AC518D19-B3F7-4E94-A88E-C3DF63BF1F9EQ38158116-12BAE4B0-C3A8-4448-A6AB-A818E5A9ACBBQ38754143-19B72A7E-5AA4-4D37-86F1-943C0504C771Q38835675-2ACD9AF1-F18F-434B-BE93-4B20FE86E324Q42554373-DDBC97C8-DD16-4FC1-B10E-92280159BCB9Q46261737-B841A538-0B47-4FFE-ACEB-51E8A0070544Q46308123-F667B035-F6FE-422E-ADE0-6522A7B120E6Q46432453-5BA1B784-1954-47F2-836D-DC40E1404F3BQ49100344-C2C41E63-889D-46AD-9882-E62F4237CAB6Q54378215-809F7FB7-99AD-4593-86D1-6F4500676759Q54442105-1FC146AF-5F3F-43EE-AB24-040A8F130309
P2860
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Angiotensin II impairs endothe ...... othelial nitric oxide synthase
@en
Angiotensin II impairs endothe ...... othelial nitric oxide synthase
@nl
type
label
Angiotensin II impairs endothe ...... othelial nitric oxide synthase
@en
Angiotensin II impairs endothe ...... othelial nitric oxide synthase
@nl
prefLabel
Angiotensin II impairs endothe ...... othelial nitric oxide synthase
@en
Angiotensin II impairs endothe ...... othelial nitric oxide synthase
@nl
P2093
P2860
P356
P1476
Angiotensin II impairs endothe ...... othelial nitric oxide synthase
@en
P2093
Annemarieke E Loot
Beate Fisslthaler
Ingrid Fleming
Judith G Schreiber
P2860
P304
P356
10.1084/JEM.20090449
P407
P577
2009-11-23T00:00:00Z